CARCINOMATOUS MENINGITIS - ANTIBODY-GUIDED THERAPY WITH I-131 HMFG1

被引：19
|
作者：
MOSELEY, RP
BENJAMIN, JC
ASHPOLE, RD
SULLIVAN, NM
BULLIMORE, JA
COAKHAM, HB
KEMSHEAD, JT
机构：
[1] FRENCHAY HOSP, DEPT NEUROSURG, BRAIN TUMOR RES LAB, BRISTOL BS16 1LE, AVON, ENGLAND
[2] FRENCHAY HOSP, DEPT NEUROPATHOL, BRISTOL BS16 1LE, AVON, ENGLAND
[3] BRISTOL ROYAL INFIRM & GEN HOSP, CTR RADIOTHERAPY, BRISTOL BS2 8HW, AVON, ENGLAND
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1991年 / 54卷 / 03期
关键词：
D O I：
10.1136/jnnp.54.3.260
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Seven patients with carcinomatous meningitis were administered intrathecal I-131 labelled monoclonal antibody HMFG1. Clinical responses were seen in two patients, with a long term survivor at 32 months. Aseptic meningitis occurred in 4/7 patients, but more serious toxicity was observed in the form of seizures (2/7 patients) and myelosuppression (3/7 patients). Partial obliteration of the subarachnoid space was identified as a potential problem in patients with advanced disease.
引用
收藏
页码：260 / 265
页数：6
相关论文
共 50 条
  • [31] POSSIBLE ERRORS IN PERIOPERATIVE ANTIBODY-GUIDED TUMOR-DETECTION USING I-131-LABELED ANTIBODIES
    OEHR, P
    SCHMIDT, S
    BRIELE, B
    WAGNER, U
    SCHULTES, B
    LIU, Q
    KINDERMANN, D
    BOCKISCH, A
    JIN, HY
    OTA, Y
    KREBS, D
    BIERSACK, HJ
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 293 - 294
  • [32] HYPOTHYROIDISM FOLLOWING I-131 THERAPY
    HAYS, MT
    JOURNAL OF NUCLEAR MEDICINE, 1982, 23 (02) : 176 - 179
  • [33] INFLUENCE OF ANTIBODY SPECIFICITY ON THE THERAPY OF MURINE LYMPHOMA WITH I-131 LABELED ANTIBODIES
    BADGER, CC
    KROHN, KA
    SHULMAN, H
    BERNSTEIN, ID
    CANCER DRUG DELIVERY, 1985, 2 (03): : 232 - 232
  • [34] ABSOLUTE UPTAKE OF I-131 HMFG2 MONOCLONAL-ANTIBODY ADMINISTERED INTRAPERITONEALLY IN MALIGNANT AND BENIGN OVARIAN-TUMORS
    MALAMITSI, J
    SKARLOS, D
    ARAVANTINOS, G
    PAPAKOSTAS, P
    VASSILAROU, S
    VARVARIGOU, A
    FOTIOU, S
    EPENETOS, AA
    KOUTOULIDIS, C
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 518 - 518
  • [35] Patient discharge instructions for I-131 Bexxar therapy vs. I-131 sodium iodide therapy
    Eveler, Amanda
    Kasecamp, Wayne
    Wahl, R.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [36] FAILURE OF PRETREATMENT I-131 RETENTION VALUES TO INFLUENCE THE OUTCOME OF I-131 THERAPY FOR THYROTOXICOSIS
    BEARDWELL, CG
    CHAPMAN, AJ
    SHALET, SM
    JOURNAL OF ENDOCRINOLOGY, 1986, 108 : 186 - 186
  • [37] IMMUNOSCINTIGRAPHY WITH I-131-LABELLED HMFG2 AND F (AB')2 HMFG1 IN THE PREOPERATIVE DETECTION OF CLINICAL AND SUBCLINICAL LYMPH-NODE METASTASES IN BREAST-CANCER
    ATHANASSIOU, A
    PECTASIDES, D
    TAYLORPAPADIMITRIOU, J
    EPENETOS, A
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 310 - 310
  • [38] Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer
    Bikas, Athanasios
    Schneider, Mark
    Desale, Sameer
    Atkins, Frank
    Mete, Mihriye
    Burman, Kenneth D.
    Wartofsky, Leonard
    Van Nostrand, Douglas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04): : 1762 - 1769
  • [39] USE OF I-131 LABEL FOR MEASUREMENT OF SERUM ANTIBODY
    COHEN, S
    FEDERATION PROCEEDINGS, 1950, 9 (01) : 380 - 380
  • [40] ANTIBODY AS CARRIER OF I-131 IN CANCER DIAGNOSIS AND TREATMENT
    GHOSE, T
    GUCLU, A
    TAI, J
    MACDONALD, AS
    NORVELL, ST
    AQUINO, J
    CANCER, 1975, 36 (05) : 1646 - 1657
12345